Denka Markova

Talazoparib in Patients with Advanced Breast Cancer and a Germline <i>BRCA</i> Mutation

Jennifer K. Litton, Hope S. Rugo, Johannes Ettl et al. · New England Journal of Medicine · 2018 · 2.2K citations · Full text

Medicine, Oncology, Pharmacology +14

Quality of life with talazoparib versus physician’s choice of chemotherapy in patients with advanced breast cancer and germline BRCA1/2 mutation: patient-reported outcomes from the EMBRACA phase III trial

Johannes Ettl, Ruben G.W. Quek, Ki Hoon Lee et al. · Annals of Oncology · 2018 · 140 citations · Full text

Medicine, Oncology, Pharmacology +11

Bupropion for the treatment of methamphetamine dependence in non-daily users: A randomized, double-blind, placebo-controlled trial

A. Anderson, Shou-Hua Li, Denka Markova et al. · Drug and Alcohol Dependence · 2015 · 69 citations

Medicine, Pharmacology, Pharmacotherapy +13

PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism

Aliya Khan, Lars Rejnmark, Mishaela R. Rubin et al. · The Journal of Clinical Endocrinology & Metabolism · 2021 · 69 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +14

A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor–Positive Breast Cancer

Ian E. Krop, Vandana G. Abramson, Marco Colleoni et al. · Clinical Cancer Research · 2020 · 65 citations · Full text

Medicine, Oncology, Pharmacology +15